This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur, Institut Pasteur Du Cambodge. Active years: 2021-2023.
Company Filing History:
2 out of 5,383 
2 out of 897 
2 out of 5 Years Active: 2021-2023
Title: Frederic Ariey: Innovator in Malaria Research
Introduction
Frederic Ariey is a notable inventor based in Choisy le Roi, France. He has made significant contributions to the field of malaria research, particularly in understanding artemisinin resistance in the Plasmodium falciparum parasite. His work has implications for global health and the fight against malaria.
Latest Patents
Frederic Ariey holds 2 patents related to molecular markers of artemisinin resistance. His latest patent focuses on the K13-propeller polymorphism, which serves as a useful molecular marker for tracking the emergence and spread of artemisinin-resistant strains of malaria. The invention includes methods, compositions, and kits designed for detecting and genotyping the presence or absence of a mutated K-13 propeller nucleic acid or protein in samples.
Career Highlights
Throughout his career, Frederic Ariey has worked with prestigious institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing the understanding of malaria resistance mechanisms.
Collaborations
Frederic has collaborated with esteemed colleagues, including Odile Puijalon and Didier Menard, to further his research efforts in malaria.
Conclusion
Frederic Ariey's innovative work in malaria research and his contributions to understanding artemisinin resistance highlight his importance in the field. His patents and collaborations reflect a commitment to improving global health outcomes.